Active Pharmaceutical IngredientIP / EP / USP
Montelukast Sodium
Description
A leukotriene receptor antagonist that reduces airway inflammation and constriction. Provides once-daily control for asthma and seasonal allergy symptoms.
Applications
Formulated into tablets and chewable tablets for asthma control and allergic rhinitis management.
Specifications
Therapeutic ClassRespiratory
AppearanceOff-White To Light Yellow Powder
Assay / Purity98.0–102.0%
SolubilityFreely Soluble In Water/Ethanol
GradeIP / USP / EP
Manufacturing ComplianceWHO-GMP / EU-GMP / USFDA
Get a tailored quotation for Montelukast Sodium within 24 business hours.